Related Experiment Videos
Differential lung ventilation after single-lung transplantation for emphysema
Jeremy B Mitchell1, Andrew D S Shaw, Simon Donald
1Department of Anaesthesia, Harefield Hospital, Harefield, Middlesex, United Kingdom.
Journal of Cardiothoracic and Vascular Anesthesia
|August 3, 2002
Summary
Differential lung ventilation effectively treats acute severe native lung hyperinflation after single-lung transplant. This method significantly improves oxygenation and is indicated when native lung compliance differs greatly from the transplanted lung.
Area of Science:
- Cardiothoracic surgery
- Pulmonary medicine
- Transplant immunology
Background:
- End-stage emphysema necessitates single-lung transplantation.
- Acute severe native lung hyperinflation is a potential post-transplant complication.
- Differential lung ventilation (DLV) is a specialized ventilatory strategy.
Purpose of the Study:
- To evaluate outcomes and respiratory function following DLV for acute severe native lung hyperinflation in single-lung transplant recipients.
- To identify criteria for initiating DLV in this patient population.
Main Methods:
- Retrospective review of 13 patients who underwent DLV for native lung hyperinflation.
- Analysis of cardiovascular and respiratory function pre- and post-DLV.
- Comparison of native lung and transplanted lung dynamic compliance.
Main Results:
- Seven out of 13 patients survived to 1 year post-transplant.
- A significant improvement in mean PaO2 was observed 1 hour after DLV initiation (p = 0.0006).
- The average ratio of dynamic compliance between native and transplanted lungs was 2.69.
Conclusions:
- DLV is an appropriate treatment for acute severe native lung hyperinflation post-single-lung transplant.
- A dynamic compliance difference of ≥2.69 between native and transplanted lungs may indicate the need for DLV.